Aquestive Therapeutics, Inc. (AQST)

NASDAQ: AQST · Real-Time Price · USD

4.730

+0.600 (14.53%)

At close: May 14, 2026, 4:00 PM EDT

4.480

-0.250 (-5.28%)

Pre-market: May 15, 2026, 5:32 AM EDT

Aquestive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	110.73	121.17	71.55	23.87	27.27	28.02
Cash & Short-Term Investments	110.73	121.17	71.55	23.87	27.27	28.02
Cash Growth	61.29%	69.36%	199.71%	-12.47%	-2.68%	-11.89%
Accounts Receivable	6.87	17.76	7.34	8.47	4.7	12.12
Inventory	8.07	6.17	6.04	6.77	5.78	4.04
Other Current Assets	4.52	4.17	3.29	1.85	2.13	3.08
Total Current Assets	130.18	149.27	88.22	40.97	39.89	47.26
Net Property, Plant & Equipment	8.31	8.51	8.98	9.74	9.3	7.78
Other Intangible Assets	-	-	-	1.28	1.44	0.05
Other Long-Term Assets	2.64	2.64	4.22	5.44	6.45	6.9
Total Assets	141.13	160.43	101.42	57.42	57.07	61.99
Accounts Payable	11.89	29.86	10.29	8.93	9.95	8.31
Accrued Expenses	3.45	5.03	5.91	6.5	7.97	8.74
Current Portion of Long-Term Debt	13.66	9.99	0.03	0.02	18.7	2.03
Current Portion of Leases	0.66	0.63	0.51	0.39	0.26	0.9
Unearned Revenue	1.09	1.09	1.05	1.55	1.51	0.77
Other Current Liabilities	1	1	1.09	0.92	1.15	1.23
Total Current Liabilities	31.75	47.61	18.87	18.31	39.53	21.96
Long-Term Debt	25.1	27.52	32.5	27.51	33.45	51.55
Long-Term Leases	4.16	4.34	4.97	5.4	5.09	1.95
Other Long-Term Liabilities	114.17	114.62	105.25	112.69	97.56	68.67
Total Long-Term Liabilities	143.43	146.48	142.72	145.6	136.1	122.16
Total Liabilities	175.18	194.09	161.58	163.91	175.62	144.13
Common Stock	0.12	0.12	0.09	0.07	0.06	0.04
Additional Paid-in Capital	420.88	413.21	302.97	212.52	192.6	174.62
Retained Earnings	-455.06	-447	-363.21	-319.08	-311.21	-256.8
Shareholders' Equity	-34.05	-33.66	-60.16	-106.49	-118.55	-82.13
Total Liabilities & Equity	141.13	160.43	101.42	57.42	57.07	61.99
Total Debt	43.58	42.48	38	33.32	57.49	56.42
Net Cash (Debt)	67.15	78.69	33.54	-9.45	-30.22	-28.4
Net Cash Growth	-14.66%	134.59%	-	-	-	-
Net Cash Per Share	0.59	0.74	0.39	-0.15	-0.62	-0.75
Book Value	-34.05	-33.66	-60.16	-106.49	-118.55	-82.13
Book Value Per Share	-0.30	-0.31	-0.69	-1.74	-2.43	-2.16
Tangible Book Value	-34.05	-33.66	-60.16	-107.77	-119.99	-82.19
Tangible Book Value Per Share	-0.30	-0.31	-0.69	-1.76	-2.46	-2.16

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q